Clinical Trial: KANGFUPEN Liquid Dressing for Chronic Radiation-Induced Rectal Injury

U.S., July 16 -- ClinicalTrials.gov registry received information related to the study (NCT07065175) titled 'KANGFUPEN Liquid Dressing for Chronic Radiation-Induced Rectal Injury' on May 25.

Brief Summary: This clinical trial aims to evaluate the efficacy and safety of Kangfupen (a topical liquid dressing) in treating chronic radiation-induced proctitis (RTOG Grade 2 or higher). The key questions we aim to answer are:

1. Does Kangfupen improve LENT-SOMA rectal injury scores after 3 months of treatment?

2. Does Kangfupen reduce endoscopic inflammation (Vienna score) and symptoms (RTOG/CTCAE grades)?

3. What adverse events occur with Kangfupen therapy? Kangfupen liquid dressing (50 mL/once daily) will be administered as retention enema fo...